1. |
Relevance: 17
6/12/2017, Site Map
|
2. |
Relevance: 17
8/6/2012, Site Map
|
3. |
Michigan CardioVascular Institute Research Department at Covenant HealthCare Joins Groundbreaking Study of Novel Regenerative Medicine Therapy for Heart Failure First-of-its-Kind Investigational Drug May Enhances Body’s Stem Cell Response at Site of Cardiovascular Injury Saginaw, MI – Michigan CardioVascular Institute (MCVI) cardiovascular disease specialists at Covenant HealthCare announced this week they have enrolled their first patient into a clinical trial of a novel gene therapy technique to promo...
Relevance: 17
7/31/2013, News
|